This article provides a comprehensive review for researchers and drug development professionals on the critical challenge of using positron emission tomography (PET) with radiolabeled antibodies for central nervous system targets.
This article provides a thorough exploration of Physiologically Based Pharmacokinetic (PBPK) modeling as a transformative tool for pediatric drug development.
This article provides a comprehensive guide for researchers and drug development professionals on the application of Physiologically-Based Pharmacokinetic (PBPK) modeling for patients with organ impairment in clinical trials.
This article provides a detailed guide to Physiologically Based Pharmacokinetic (PBPK) modeling for oral Selective Estrogen Receptor Degraders (SERDs).
This article provides a detailed exploration of Physiologically Based Pharmacokinetic (PBPK) modeling for large molecule therapeutics, including monoclonal antibodies and other proteins.
This article provides a comprehensive analysis of Physiologically Based Pharmacokinetic (PBPK) modeling, contrasting its application and performance for large-molecule biologics against traditional small molecules.
This comprehensive guide for drug development professionals and researchers explores the critical process of Physiologically-Based Pharmacokinetic (PBPK) model parameter estimation and the software platforms enabling it.
This article provides a comprehensive review and comparison of Physiologically-Based Pharmacokinetic (PBPK) and Population Pharmacokinetic (popPK) modeling approaches in critically ill patients.
This article provides a comprehensive, current review of the NF-κB signaling pathway's central role in inflammation and immunity.
This article provides a detailed analysis of the MRI-guided hyperosmotic mannitol protocol for blood-brain barrier (BBB) disruption, a critical technique in CNS therapeutic delivery.